학술논문
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.
Document Type
Article
Author
Unger, Joseph M.; Darke, Amy; Othus, Megan; Truong, Thach-Giao; Khushalani, Nikhil; Kendra, Kari; Lewis, Karl D.; Faller, Bryan; Funchain, Pauline; Buchbinder, Elizabeth I.; Tarhini, Ahmad A.; Kirkwood, John M.; Sharon, Elad; Sondak, Vernon; Guild, Samantha R.; Grossmann, Kenneth; Ribas, Antoni; Patel, Sapna P.
Source
JAMA Oncology; Feb2023, Vol. 9 Issue 2, p251-260, 10p
Subject
Language
ISSN
23742437